“Our groundbreaking discovery, which is based on the right activation of the right T cells, builds on the foundations laid by T cell therapeutics such as checkpoint inhibitors, chimeric antigen ...

Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

Immune cells called regulatory T cells have long been known for their role in countering inflammation ... Earlier work led by ...

Researchers have developed a groundbreaking AI model that identifies tumor-fighting immune cells, enhancing cancer ...

The researchers engineered cancer cells to re-express Parkin and found that Parkin contributes to the production of interferons, which activate and attract T cells to fight the tumor. The findings ...

Researchers at Cellectis leveraged gene editing to create a CAR T cell that acts in an IF/THEN system. Traditional methods to develop CAR T cells that use the patient’s cells introduce challenges ...